Literature DB >> 14702496

Deep venous thrombosis in children with diabetic ketoacidosis and femoral central venous catheters.

Julia M Worly1, James D Fortenberry, Inger Hansen, C Robert Chambliss, Jana Stockwell.   

Abstract

OBJECTIVE: To describe findings of deep venous thrombosis (DVT) in association with femoral central venous catheter (CVC) placement for intensive fluid management in children with diabetic ketoacidosis (DKA) secondary to type 1 diabetes.
DESIGN: Retrospective cohort study.
SETTING: Pediatric intensive care unit (PICU) of a children's referral medical center. PATIENTS: DKA patients from 1998 to 2002 of children with DKA with and without CVC placement. DKA patients were also compared with all PICU patients with CVC. CVC DVT was defined as ipsilateral leg swelling with CVC placement, confirmed by radiographic study, and persisting after CVC removal.
MEASUREMENTS AND MAIN RESULTS: Of 113 DKA PICU patients, 6 (5.3%) required femoral CVC for initial management. Three of these DKA/CVC patients developed ipsilateral DVT within 48 hours of CVC placement. All 3 patients required long-term therapy with low molecular weight heparin for persistent leg swelling. DKA/CVC patients with DVT were younger (median age: 10.5 months) than DKA/CVC patients without DVT. The number of DKA/CVC patients with DVT (1.4%) was significantly greater than for all femoral non-DKA/CVC patients. DKA/CVC patients were also significantly more likely to have DVT than age-matched shock/CVC patients. They also had significantly higher glucose, corrected sodium concentrations, and lower pH and serum bicarbonate than did age-matched shock/CVC patients.
CONCLUSIONS: Femoral CVC placement is infrequently needed in pediatric DKA patients but can be associated with DVT. Femoral CVCs should be avoided in DKA patients or removed as soon as possible. DVT prophylaxis should be considered if a CVC is required.

Entities:  

Mesh:

Year:  2004        PMID: 14702496     DOI: 10.1542/peds.113.1.e57

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  11 in total

Review 1.  Hyperglycemic comas in children: new insights into pathophysiology and management.

Authors:  Arlan L Rosenbloom
Journal:  Rev Endocr Metab Disord       Date:  2005-12       Impact factor: 6.514

2.  DKA and thrombosis.

Authors:  Jeff Burzynski
Journal:  CMAJ       Date:  2005-07-19       Impact factor: 8.262

Review 3.  Rare complications of pediatric diabetic ketoacidosis.

Authors:  Shara R Bialo; Sungeeta Agrawal; Charlotte M Boney; Jose Bernardo Quintos
Journal:  World J Diabetes       Date:  2015-02-15

4.  Extensive venous thrombosis of the upper extremity in a diabetic patient with a hyperosmolar hyperglycemic state.

Authors:  Juri Park; Dong Jin Kim; Hee Young Kim; Ji A Seo; Sin Gon Kim; Sei Hyun Baik; Dong Seop Choi
Journal:  Korean J Intern Med       Date:  2006-12       Impact factor: 2.884

Review 5.  Management of diabetic ketoacidosis in children and adolescents.

Authors:  Nicole A Sherry; Lynne L Levitsky
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

6.  Blood glucose as a marker of venous thromboembolism in critically ill children.

Authors:  J A Tala; C T Silva; S Pemira; E Vidal; E V S Faustino
Journal:  J Thromb Haemost       Date:  2014-06       Impact factor: 5.824

7.  Diabetic ketoacidosis-associated stroke in children and youth.

Authors:  Jennifer Ruth Foster; Gavin Morrison; Douglas D Fraser
Journal:  Stroke Res Treat       Date:  2011-02-22

8.  The management of diabetic ketoacidosis in children.

Authors:  Arlan L Rosenbloom
Journal:  Diabetes Ther       Date:  2011-01-12       Impact factor: 2.945

9.  Presumed paradoxical embolus in a patient with diabetic ketoacidosis.

Authors:  Catherine Langevin; Caroline Lamarche; Robert Z Bell; Michel Vallée
Journal:  Int J Gen Med       Date:  2015-09-18

10.  Diabetic Ketoacidosis with Extreme Hypernatremia in a 4-Year-Old Girl.

Authors:  Manish Kumar Arya; Sheikh Minhaj Ahmed; Krishnakumar N Shah; Uma S Ali
Journal:  Indian J Crit Care Med       Date:  2017-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.